RedHill Biopharma Ltd. (RDHL) Financials

RDHL Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 18.4 million 22.8 million
March 31, 2025 18.4 million 22.8 million
Dec. 31, 2024 18.0 million 22.7 million
Sept. 30, 2024 18.0 million 22.7 million

RDHL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -2.5 million 148500
March 31, 2025 -2.5 million 148500
Dec. 31, 2024 -1.6 million 218000
Sept. 30, 2024 -1.6 million 218000

RDHL Net Income

No data available :(

RDHL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 2.9 million - 214000
March 31, 2025 2.9 million - -
Dec. 31, 2024 - - 356000
Sept. 30, 2024 4.6 million - -

RDHL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 1.8 million
March 31, 2025 1.8 million
Dec. 31, 2024 2.6 million
Sept. 30, 2024 2.6 million

RDHL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 2000 482000 1.9 million 1.0 million
March 31, 2025 2000 482000 1.9 million 1.0 million
Dec. 31, 2024 4000 464500 3.3 million 1.2 million
Sept. 30, 2024 4000 464500 2.0 million 1.2 million

RDHL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 2.0 million 803500
March 31, 2025 2.0 million 803500
Dec. 31, 2024 2.7 million 894000
Sept. 30, 2024 2.7 million 894000

RDHL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

RDHL

Price: $1.03

52 week price:
0.71
3.31

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Israel

Volume: 100.7 million

Ebitda: -13.8 million

Market Capitalization: 3.4 million

Links: